MUMBAI, India, April 10 -- Intellectual Property India has published a patent application (202647040617 A) filed by Genfit, Loos, France, on March 31, for 'methods for the screening of patients with at-risk metabolic dysfunction-associated steatohepatitis (mash).'
Inventor(s) include Hajji, Yacine; and Magnanensi, Jeremy.
The application for the patent was published on April 10, under issue no. 15/2026.
According to the abstract released by the Intellectual Property India: "Provided herein is a method for the screening of patients with at-risk MASH (metabolic dysfunction-associated steatohepatitis, formerly named nonalcoholic steatohepatitis or NASH). The combination of levels of five circulating markers, i.e. alanine aminotransferase (ALAT), aspartate transaminase (ASAT), platelets, hsa-miR-34a and YKL-40 in a subject, and eventually the age and gender of said subject, allows to accurately identify non-cirrhotic at-risk MASH. The information obtained from the levels of these markers also allows to screen a subject as being eligible to liver biopsy and/or to classify a subject as a receiver or non-receiver of a treatment of MASH and/or to classify a subject as a responder or non-responder of a treatment of MASH."
The patent application was internationally filed on Oct. 09, 2024, under International application No.PCT/EP2024/078331.
Disclaimer: Curated by HT Syndication.
